Abstract: Allosteric regulation underlies living cells' ability to sense changes in nutrient and signaling-molecule concentrations, but the ability to computationally design allosteric regulation into non-allosteric proteins has been elusive. Allosteric-site design is complicated by the requirement to encode the relative stabilities of active and inactive conformations of the same protein in the presence and absence of both ligand and effector. To address this challenge, we used Rosetta to design the backbone of the flexible heavy-chain complementarity-determining region 3 (HCDR3), and used geometric matching and sequence optimization to place a Zn 21 -coordination site in a fluorescein-binding antibody. We predicted that due to HCDR3's flexibility, the fluorescein-binding pocket would configure properly only upon Zn 21 application. We found that regulation by Zn 21 was reversible and sensitive to the divalent ion's identity, and came at the cost of reduced antibody stability and fluorescein-binding affinity. Fluorescein bound at an order of magnitude higher affinity in the presence of Zn 21 than in its absence, and the increase in fluorescein affinity was due almost entirely to faster fluorescein on-rate, suggesting that Zn 21 preorganized the antibody for fluorescein binding. Mutation analysis demonstrated the extreme sensitivity of Zn 21 regulation on the atomic details in and around the metal-coordination site. The designed antibody could serve to study how allosteric regulation evolved from non-allosteric binding proteins, and suggests a way to designing molecular sensors for environmental and biomedical targets.
Introduction
All cells must sense changes in the concentrations of metabolites and signaling molecules to regulate their growth and development. At the molecular level, regulation is typically encoded by effector-molecule binding to an allosteric site in a protein (a site that is spatially distinct and nonoverlapping with the active site); effector binding must furthermore induce a conformational change in the active site, thereby modulating the protein's activity. 1 Recent experimental and theoretical work has suggested that allosteric regulation relies on the intrinsic flexibility observed to a different extent in all proteins, and the ability of effector binding or change in environmental conditions to shift the major conformational species between active and inactive (or partly active) states. 2, 3 Over the past decade, regulation was engineered and in vitro evolved, 4 for instance, by fusing naturally occurring binding domains to other binders and Abbreviations: EDTA, ethylenediaminetetraacetic acid; Fv, antibody variable fragment; HCDR3, heavy-chain complementaritydetermining region 3; scFv, single-chain Fv; SPR, surface plasmon resonance Additional Supporting Information may be found in the online version of this article.
Statement: Using backbone design in Rosetta, we designed a Zn 21 -binding site into the variable domain of a fluoresceinbinding antibody, so that the fluorescein-binding pocket would configure properly only upon Zn 21 application. Regulation by Zn 21 was reversible and sensitive to the divalent ion's identity, and came at the cost of stability and fluorescein-binding affinity. This strategy could be used to design molecular sensors for environmental and biomedical purposes.
enzymes, [5] [6] [7] [8] by rational design of an active site for a model reaction into an already allosteric protein, [9] [10] [11] and by modifying the allosteric site's effector specificity. 12 Regulation was also demonstrated by "chemical rescue," whereby an amino acid sidechain at the active site was eliminated, making activity conditional on binding of a mimic of the sidechain. 13, 14 Despite these achievements, the design of an allosteric regulatory site into a protein through computational modeling has not been demonstrated. This design goal is moreover complicated because it requires design of different conformations with very similar free energies in the same protein.
Computational protein design, by contrast, has focused almost exclusively on proteins with one stable conformation. 15 To address this challenge, we decided to design an allosteric regulatory site into an antibody. Antibodies have several advantages for design of an allosteric site: foremost, antibodies are the most versatile class of binding molecules in nature, able to bind small molecules as well as large macromolecules with high affinity and specificity; the ability to design allosteric regulation in antibodies could therefore pave the way to design of allosteric binders in numerous cases. Second, there are >1,000 antibody structures in the Protein Data Bank (PDB), providing ample data on potential backbone conformations; and third, the antibody variable fragment (Fv) is modular, facilitating recombination of different backbones to generate diverse new conformations. Despite these important advantages, however, allosteric regulation is not known to occur in natural antibody variable fragments, and was not demonstrated by protein engineering, and therefore required a novel design strategy.
Results
We chose the high-affinity fluorescein-binding antibody 4m5.3 (PDB entry: 1X9Q; K D 5 3 3 10 213 M) as a target for design, 16 Fig. 1(B) ]. In this design procedure, the backbone from 4m5.3 is modeled as the starting structure in all regions except HCDR3, and the entire HCDR3 backbone is replaced with the one observed in each We tested 71 designs that passed our structure and energy filters using yeast cell surface display (Supporting Information Table SI) . 26 Genes encoding the antibodies were formatted as single-chain variable fragments (scFv), cloned into the pETCON yeast display vector, 27 and used to transform yeast EBY100 cells. (Fig. 2) . We also noted that D5's expression levels were <50% those of 4m5.3, indicating reduced stability. 28 Because fluorescein binding quenches its fluorescence, the probe used in our yeast-display experiments was biotinylated fluorescein conjugated to the fluorescent streptavidin-APC. 29 To verify that the binding signal observed in these experiments was due to fluorescein and not to the much larger streptavidin-APC moiety, we next tested D5 binding to biotinylated fluorescein in the presence and absence of Zn 21 . D5 scFv was expressed in E. coli BL21 cells, isolated from inclusion bodies, refolded, and seen to be mostly monomeric on size-exclusion chromatography (>80%; Supporting Information Fig. S2 ). We then measured binding to biotinylated fluorescein by surface-plasmon resonance. The apparent K D in the absence of Zn 21 was nearly tenfold higher than in its presence (3.2 mM and 0.4 mM, respectively), and the response to fluorescein was 2-to 4-fold higher (depending on fluorescein concentration) in the presence of 50 mM Zn 21 than in its absence (Fig. 3 , Supporting Information Fig. S3(A) 21 . The design therefore has some of the selectivity, sensitivity, and reversibility hallmarks of natural molecular sensors.
Discussion
We designed a sensitive and reversible allosteric regulation site in an antibody variable domain by optimizing HCDR3 and surrounding residues for Zn 21 coordination. The design of allosteric regulation demands control over multiple protein states, a challenge that has only been addressed in a few cases. 31, 32 Here, instead, we explicitly designed only the target ligand-and effector-bound state and predicted that the effector-unbound state would be flexible, thereby reducing its affinity for the ligand. Although successful, the designed allosteric site came at the cost of reduced stability and lower affinity for the ligand fluorescein; it is also noteworthy that we only obtained one design with the desired activity profile from 71 tested, further emphasizing the challenge of balancing the conflicting requirements of protein flexibility, stability, and binding. We speculate that natural allosteric proteins might have emerged from non-allosteric binding proteins through similar intermediates, in which effector responsiveness came at a cost to stability, ligand-affinity, or both. D5 may therefore serve to investigate the emergence of allosteric regulation from non-allosteric binding proteins during evolution. The mutation analysis reported above, however, demonstrates D5's extreme sensitivity to conservative point mutations, whereas many natural allosteric proteins show remarkable plasticity and an ability to change regulatory characteristics through evolution. 33 D5's relative intolerance to mutation may stem from the fact that the designed allosteric site is spatially closer to the substrate-binding site than often seen in natural proteins. Finally, we note that given the ubiquity of antibodies in research, the design algorithm may provide a way to rational design of sensitive and regulated molecular sensors. Gene synthesis, cloning, and mutagenesis
Materials and Methods

Design
The genes of the 71 designed scFvs (14, 23 , and 34 designs with HHH, DHH, and EHH-coordination geometry, respectively) were synthesized by Gen9, Inc. (Cambridge, MA) and cloned into the pETCON vector by homologous recombination upon transformation into yeast. 35 The gene of design D5 for bacterial expression was ordered from Genscript (Piscataway, NJ) in pET29b vector. Point mutations were introduced by QuickChange protocol 36 (Supporting Information Table SII ). The gene encoding design D5 will be deposited upon publication in AddGene. 
Yeast surface display
D5 scFv expression and purification from inclusion bodies
The scFvs were produced essentially as described, 38 with EDTA omitted in all the steps.
Surface plasmon resonance (SPR)
SPR experiments were carried out using BIAcore T200 (GE Healthcare). Experiments were performed at 258C in 10 mM HEPES pH 7.4, 150 mM NaCl, and 0.005% Tween 20 (running buffer). Design D5 was immobilized on a CM5 chip (GE Healthcare) by amine coupling to a total of roughly 5,000 response units (RU). Running buffer with 50 lM ZnCl 2 was injected for 1,800 s at 2 lL min 21 , and then for 600 s before each injection of analyte. A concentration series of biotinylated fluorescein (1, 2, 4, 8, and 32 lM in running buffer) was injected over the coated chip for 240s at 10 lL min 21 , followed by 600-s dissociation. In the experiment without Zn
21
, running buffer with 1mM EDTA was injected for 1,800s at 2 lL min 21 , before analyte injections. Specific binding was obtained by subtracting the response of a blank surface from that of the surface coated by design D5. The data were analyzed using BIAevaluation 4.1.1 software and fitted to the heterogeneous ligand with parallel reactions model. The data from flowing 2 lM analyte without Zn 21 were excluded from parameter fitting for inconsistency with the other traces, but are shown in Figure 3 for completeness.
